The CE mark makes it possible for cancer treatment centers to begin ordering, installing, and using the Varian proton therapy system in regions where CE mark is required without having to obtain a site-specific clearance to use this important technology, the company said.
Through R&D and the acquisition of Accel in Germany during 2007, Varian has developed a comprehensive proton therapy system that utilizes the company’s technology for particle beam generation, treatment planning, imaging, motion management, and information management technology.
Lester Boeh, vice president of emerging businesses at Varian, said: CE mark is an important milestone in Varian’s initiative to develop and market a compact system capable of intensity-modulated proton therapy in single- or multi-room facilities.
This is a clear demonstration of our ongoing commitment to provide the cancer treatment community and its patients with a clinically practical and commercially viable proton therapy system that meets accepted safety standards for medical equipment.